BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25381785)

  • 1. [Incidence and factors influencing oral mucositis in patients with hematopoietic stem cell transplantation].
    Jo KS; Kim NC
    J Korean Acad Nurs; 2014 Oct; 44(5):542-51. PubMed ID: 25381785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
    Chen J; Seabrook J; Fulford A; Rajakumar I
    J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
    Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
    Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation.
    Bhatt V; Vendrell N; Nau K; Crumb D; Roy V
    J Oncol Pharm Pract; 2010 Sep; 16(3):195-204. PubMed ID: 19910393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
    Kim KI; Kim JW; Lee HJ; Kim BS; Bang SM; Kim I; Oh JM; Yoon SS; Lee JS; Park S; Kim BK
    Am J Hematol; 2013 Feb; 88(2):107-12. PubMed ID: 23225026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
    Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
    Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.
    Sonis ST; Oster G; Fuchs H; Bellm L; Bradford WZ; Edelsberg J; Hayden V; Eilers J; Epstein JB; LeVeque FG; Miller C; Peterson DE; Schubert MM; Spijkervet FK; Horowitz M
    J Clin Oncol; 2001 Apr; 19(8):2201-5. PubMed ID: 11304772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
    Nguyen DT; Shayani S; Palmer J; Dagis A; Forman SJ; Epstein J; Spielberger R
    Support Care Cancer; 2015 Nov; 23(11):3141-7. PubMed ID: 25791390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
    Langner S; Staber P; Schub N; Gramatzki M; Grothe W; Behre G; Rabitsch W; Urban C; Linkesch W; Neumeister P
    Bone Marrow Transplant; 2008 Aug; 42(4):275-9. PubMed ID: 18500368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis.
    Czyzewski K; Debski R; Krenska A; Wysocki M; Styczynski J
    Anticancer Res; 2014 Dec; 34(12):7379-82. PubMed ID: 25503176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
    Robien K; Schubert MM; Bruemmer B; Lloid ME; Potter JD; Ulrich CM
    J Clin Oncol; 2004 Apr; 22(7):1268-75. PubMed ID: 15051775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases.
    Vitale KM; Violago L; Cofnas P; Bishop J; Jin Z; Bhatia M; Kung AL; George D; Garvin J; Satwani P
    Pediatr Transplant; 2014 Mar; 18(2):211-6. PubMed ID: 24823628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
    J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation.
    Bezinelli LM; de Paula Eduardo F; da Graça Lopes RM; Biazevic MG; de Paula Eduardo C; Correa L; Hamerschlak N; Michel-Crosato E
    Hematol Oncol; 2014 Mar; 32(1):31-9. PubMed ID: 23625880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
    Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
    Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.
    Kashiwazaki H; Matsushita T; Sugita J; Shigematsu A; Kasashi K; Yamazaki Y; Kanehira T; Kondo T; Endo T; Tanaka J; Hashino S; Nishio M; Imamura M; Kitagawa Y; Inoue N
    Support Care Cancer; 2012 May; 20(5):933-9. PubMed ID: 21494780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caphosol(®) mouthwash gives no additional protection against oral mucositis compared to cryotherapy alone in stem cell transplantation. A pilot study.
    Svanberg A; Öhrn K; Birgegård G
    Eur J Oncol Nurs; 2015 Feb; 19(1):50-3. PubMed ID: 25224595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral health as a predictive factor for oral mucositis.
    Coracin FL; Santos PS; Gallottini MH; Saboya R; Musqueira PT; Barban A; Chamone Dde A; Dulley FL; Nunes FD
    Clinics (Sao Paulo); 2013 Jun; 68(6):792-6. PubMed ID: 23778491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.